MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
about
Progress and perspectives on targeting nanoparticles for brain drug delivery.MicroRNAs in glioblastoma multiforme pathogenesis and therapeuticsDevelopment of targeted therapies in treatment of glioblastomaGetting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrierNovel delivery approaches for cancer therapeutics.Micro RNA-98 suppresses interleukin-10 in peripheral B cells in patient post-cardio transplantation.pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery.MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cellsBiodegradable DNA Nanoparticles that Provide Widespread Gene Delivery in the BrainGemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy.AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells.Enhancing the pharmacokinetic/pharmacodynamic properties of therapeutic nucleotides using lipid nanoparticle systems.Chlorotoxin: Structure, activity, and potential uses in cancer therapy.Biodegradable brain-penetrating DNA nanocomplexes and their use to treat malignant brain tumors.A biodistribution study of solid lipid-polyethyleneimine hybrid nanocarrier for cancer RNAi therapy.Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells.miRNA nanotherapeutics for cancer.Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy.Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer.Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications.Brain-Targeted Polymers for Gene Delivery in the Treatment of Brain Diseases.miRNAs: micro-managers of anticancer combination therapies.Nanoparticles as new tools for inhibition of cancer angiogenesis.Micro RNA-155 plays a critical role in the initiation of food allergen-related inflammation in the intestineRNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials.High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors.Multiplexed nanomedicine for brain tumors: nanosized Hercules to tame our Lernaean Hydra inside?A curcumin-loaded polymeric micelle as a carrier of a microRNA-21 antisense-oligonucleotide for enhanced anti-tumor effects in a glioblastoma animal model.Nanoparticle/siRNA-based therapy strategies in glioma: which nanoparticles, which siRNAs?Use of nanoparticles for glioblastoma treatment: a new approach.Dual-Function Polymeric HPMA Prodrugs for the Delivery of miRNA.Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells.Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in Cancer.Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models.Non-Viral Based miR Delivery and Recent Developments.Development of bioactive materials for glioblastoma therapy.
P2860
Q26740580-F9CF19B9-5CE1-47AE-B74C-AD5AF6A87B39Q26747273-35AC3160-FDEA-4FBA-B5A9-8B0ABCBCB66CQ26778787-328645C9-7AA2-480B-B39D-F5A27DC549EFQ28071873-EBEA5246-8FB5-493D-B90E-911F52391C62Q30368171-AECD717A-0351-4E61-BB4F-1631748AE4E3Q33709652-3D7A5A08-2FB4-40ED-8531-EEABFA4B45E2Q36137279-F9AEDA3F-F6EE-4528-B3A7-142D3C0DD6EDQ36262217-0A0C47AE-4957-402E-9A71-8BCEDD6A484FQ37019334-17656871-2170-4D1E-BEB8-29DE012692A3Q37550964-298B4287-18EE-498C-94D8-58624D47C560Q37690850-E91F0ED3-D028-4A24-BD39-948EBA332CCFQ38591825-E033ED4D-82A6-4078-99D8-05853863AD2DQ38595154-CB105057-6480-494A-9BC5-DE7A817951C3Q38685603-03627140-BD72-4FE0-8156-45F9CCD1E71AQ38749605-9FC276E9-33E3-4AAB-8CE2-8D0D42766005Q38765826-713183D9-28A2-435C-A925-3D71CCD0A912Q38999082-EB0A9491-49BB-4179-9FAE-2E697631BB9DQ39065397-6A32897D-8C52-4C91-BF22-40664CFB8984Q39196485-079351A0-B863-456C-B391-036785266B4CQ39218100-15E67454-BBC3-4282-9BA5-D9C4985701C3Q39233422-59A89F74-EC7D-4D6F-BC59-F8EE7136BA64Q39285150-15AE3B53-2931-4E39-9B14-DAD771347395Q39329359-CACA71F7-8469-41CF-9B90-50CEBC3E167EQ42366555-45D8360F-4BB2-4D11-BA29-CBFEF35E3E1CQ45871459-B1C23F7D-7940-4C79-9F23-6A3487317E37Q47433079-CD10DBA5-6CA6-437E-8948-8D1A9BE27AE0Q47606186-2F00A5FB-F38F-47F2-815C-5AE6F9EED367Q47607623-C81683C8-1D34-4B15-B3A5-82C0B2FD2C7AQ47860853-3A952414-310F-425C-B32C-D891F3255D1BQ47937284-D98C595F-C3F1-4CB4-AEFF-8201B9149BCBQ48095060-86853C32-86C2-4566-9D6F-F2A03E2D79DCQ48298916-A94ED550-3DE1-45D6-A6DD-074F2A5EA457Q50098046-0AA5184F-2F6C-4B7C-9AE7-D2D059809437Q50109651-BAB4FC62-8CE2-47DF-8392-44DF066E625CQ54111592-622AA34F-F09D-4CCC-9E0D-F037D0AD5E50Q54231141-9AEDC2D4-6E78-4788-8B95-88EE7626B69CQ54955140-B51A1453-AB11-466A-9661-D2FAA5828C65
P2860
MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MiRNA-21 silencing mediated by ...... apy approach for glioblastoma.
@en
type
label
MiRNA-21 silencing mediated by ...... apy approach for glioblastoma.
@en
prefLabel
MiRNA-21 silencing mediated by ...... apy approach for glioblastoma.
@en
P50
P921
P1476
MiRNA-21 silencing mediated by ...... rapy approach for glioblastoma
@en
P2093
Pedro M Costa
P356
10.1016/J.JCONREL.2015.04.002
P407
P577
2015-04-07T00:00:00Z